Chen I-Hsuan Alan, Chang Chao-Hsiang, Huang Chi-Ping, Wu Wen-Jeng, Li Ching-Chia, Chen Chung-Hsin, Huang Chao-Yuan, Lo Chi-Wen, Yu Chih-Chin, Tsai Chung-You, Wu Wei-Che, Tseng Jen-Shu, Lin Wun-Rong, Jiang Yuan-Hong, Lee Yu-Khun, Jou Yeong-Chin, Cheong Ian-Seng, Hsueh Thomas Y, Chiu Allen W, Chen Yung-Tai, Chen Jih-Sheng, Chiang Bing-Juin, Tsai Yao-Chou, Lin Wei Yu, Wu Chia-Chang, Lin Jen-Tai, Yu Chia-Cheng
Division of Urology, Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Institute of Clinical Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Front Oncol. 2022 Jan 13;11:766576. doi: 10.3389/fonc.2021.766576. eCollection 2021.
Taiwan is one of the endemic regions where upper tract urothelial carcinoma (UTUC) accounts for approximately a third of all urothelial tumors. Owing to its high prevalence, extensive experience has been accumulated in minimally invasive radical nephroureterectomy (RNU). Although a variety of predictive factors have been explored in numerous studies, most of them were on a single-center or limited institutional basis and data from a domestic cohort are lacking.
This study aims to identify significant predicting factors of oncological outcomes, including overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and intravesical recurrence-free survival (IVRFS), following RNU for UTUC in Taiwan.
A multicenter registry database, Taiwan UTUC Collaboration Group, was utilized to analyze oncological outcomes of 3,333 patients undergoing RNU from 1988 to 2021 among various hospitals in Taiwan. Clinicopathological parameters were recorded according to the principles established by consensus meetings. The Kaplan-Meier estimator was utilized to estimate the survival rates, and the curves were compared using the stratified log-rank test. Univariate and multivariate analyses were performed with the Cox proportional hazard model to explore potential predicting factors.
With a median follow-up of 41.8 months in 1,808 patients with complete information, the 5-year IVRFS, DFS, CSS, and OS probabilities were 66%, 72%, 81%, and 70%, respectively. In total, 482 patients experienced intravesical recurrence, 307 died of UTUC, and 583 died of any cause. Gender predominance was female (57%). A total of 1,531 patients (84.7%) had high-grade tumors; preoperative hydronephrosis presented in 1,094 patients (60.5%). Synchronous bladder UC was identified in 292 patients (16.2%). Minimally invasive procedures accounted for 78.8% of all surgeries, including 768 hand-assisted laparoscopic (42.5%) and 494 laparoscopic (27.3%) approaches. Synchronous bladder UC was the dominant adverse predicting factor for all survival outcomes. Other independent predicting factors for OS, CSS, and DFS included age ≧70, presence of preoperative hydronephrosis, positive surgical margin, LVI, pathological T and N staging, and laparoscopic RNU.
Synchronous UC of the urinary bladder is an independent adverse prognostic factor for survival in UTUC. The presence of preoperative hydronephrosis was also corroborated as a disadvantageous prognostic factor. Our multivariate analysis suggested that laparoscopic RNU might provide better oncological control.
台湾是上尿路尿路上皮癌(UTUC)的流行地区之一,UTUC约占所有尿路上皮肿瘤的三分之一。由于其高发病率,在微创根治性肾输尿管切除术(RNU)方面积累了丰富经验。尽管众多研究探索了多种预测因素,但大多数研究是基于单中心或有限机构,缺乏来自国内队列的数据。
本研究旨在确定台湾UTUC患者行RNU术后肿瘤学结局的显著预测因素,包括总生存期(OS)、癌症特异性生存期(CSS)、无病生存期(DFS)和膀胱内无复发生存期(IVRFS)。
利用多中心注册数据库台湾UTUC协作组,分析1988年至2021年台湾各医院3333例行RNU患者的肿瘤学结局。根据共识会议确定的原则记录临床病理参数。采用Kaplan-Meier估计器估计生存率,并使用分层对数秩检验比较曲线。采用Cox比例风险模型进行单因素和多因素分析,以探索潜在的预测因素。
1808例有完整信息的患者中位随访41.8个月,5年IVRFS、DFS、CSS和OS概率分别为66%、72%、81%和70%。共有482例患者发生膀胱内复发,307例死于UTUC,583例死于任何原因。性别以女性为主(57%)。共有1531例患者(84.7%)为高级别肿瘤;1094例患者(60.5%)术前存在肾积水。292例患者(16.2%)发现同步膀胱UC。微创手术占所有手术的78.8%,包括768例手辅助腹腔镜手术(42.5%)和494例腹腔镜手术(27.3%)。同步膀胱UC是所有生存结局的主要不良预测因素。OS、CSS和DFS的其他独立预测因素包括年龄≥70岁、术前肾积水、手术切缘阳性、淋巴管浸润、病理T和N分期以及腹腔镜RNU。
膀胱同步UC是UTUC患者生存的独立不良预后因素。术前肾积水的存在也被证实为不利的预后因素。我们的多因素分析表明,腹腔镜RNU可能提供更好的肿瘤学控制。